NCT03164382 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT03153332 Value of 3D Printing for Comprehension of Liver Surgical Anatomy Status COMPLETED Phase N/A
NCT03143270 A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03131778 The Inflammatory Response to Stress and Angiogenesis in Liver Resection Status COMPLETED Phase NA
NCT03111732 Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) Status COMPLETED Phase PHASE2
NCT03063840 Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels Status WITHDRAWN Phase NA
NCT03059238 Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure Status COMPLETED Phase PHASE3
NCT03058289 A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 Status COMPLETED Phase PHASE1/PHASE2
NCT03026803 A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer Status TERMINATED Phase PHASE2
NCT03026452 Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02989870 Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE1
NCT02984566 Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) Status ACTIVE_NOT_RECRUITING Phase NA
NCT02966223 A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver Status TERMINATED Phase NA
NCT02960620 Therasphere for Unresectable Primary or Secondary Liver Neoplasia Status NO_LONGER_AVAILABLE Phase N/A
NCT02941861 Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery Status COMPLETED Phase N/A
NCT02932956 Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02869217 Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1